Paracetamol: A Review of Guideline Recommendations
Open accessThe DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
Musculoskeletal pain conditions are age-related, leading contributors to chronic pain and pain-related disability, which are expected to rise with the rapid global population aging. Current medical treatments provide only partial relief. Furthermore, non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are effective in young and otherwise healthy individuals but are often contraindicated in elderly and frail patients. As a result of its favorable safety and tolerability record, paracetamol has long been the most common drug for treating pain. Strikingly, recent reports questioned its therapeutic value and safety. This review aims to present guideline recommendations. Paracetamol has been assessed in different conditions and demonstrated therapeutic efficacy on both acute and chronic pain. It is active as a single agent and is additive or synergistic with NSAIDs and opioids, improving their efficacy and safety. However, a lack of significant efficacy and hepatic toxicity have also been reported. Fast dissolving formulations of paracetamol provide superior and more extended pain relief that is similar to intravenous paracetamol. A dose reduction is recommended in patients with liver disease or malnourished. Genotyping may improve efficacy and safety. Within the current trend toward the minimization of opioid analgesia, it is consistently included in multimodal, non-opioid, or opioid-sparing therapies. Paracetamol is being recommended by guidelines as a first or second-line drug for acute pain and chronic pain, especially for patients with limited therapeutic options and for the elderly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is recommended for fever, acute pain, chronic pain, postoperative recovery, musculoskeletal disorders, pregnancy-associated discomfort, pediatric illnesses, and palliative care [ 2 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For short-term treatment of acute pain and fever robust evidence continues to support both its efficacy and comparative safety [ 1 , 2 , 20 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One thing that is already accepted in the scientific community is that paracetamol has almost no anti-inflammatory activity and does not cause the same adverse effects as NSAIDs do.5”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although it was introduced in clinics more than 100 years ago,4 paracetamol remains the recommended first-line option for pain management by several scientific societies, and particularly in vulnerable populations such as geriatrics, children, patients with peptic ulcers, and pregnant women.5,6”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Paracetamol continues to occupy a privileged position within healthcare systems despite growing uncertainty regarding its efficacy in many chronic pain conditions [ 2 , 9 , 18 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482 · cited 2×
“However, in cancer patients, early pain therapy is critical not only to reduce pain discomfort but slow the disease progression and improve survival [58].”
BackgroundHunter, D. J., & Bierma-Zeinstra, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30417-9 · Cited by 4,795
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 1,965
OARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Oliveira, C. B., Maher, C. G., Pinto, R. Z., Traeger, A. C., Lin, C.-W. C., Chenot, J.-F., van Tulder, M., & Koes, B. W. (2018) · European Spine Journal · doi:10.1007/s00586-018-5673-2 · Cited by 1,584 · cited 1×
“However, recently, paracetamol failed to show superiority over placebo, and questions have been raised about its safety [70].”
Background2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
van der Heijde, D., Ramiro, S., Landewé, R., Baraliakos, X., Van den Bosch, F., Sepriano, A., Regel, A., Ciurea, A., Dagfinrud, H., Dougados, M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210770 · Cited by 1,568
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Cited by
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
“NSAIDs are commonly used for the management of conditions such as muscle pain, dysmenorrhea, arthritic conditions, pyrexia, gout, migraines, and as opioid-sparing agents in certain acute trauma cases [103].”
BackgroundAcademy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022
Mitchell, K. B., Johnson, H. M., Rodríguez, J. M., Eglash, A. R., Scherzinger, C., Widmer, K., Berens, P., & Miller, B. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2022.29207.kbm · Cited by 143
“Ibuprofen can be dosed 800 mg every 8 hours 37 and acetamino-phen/paracetamol 1,000 mg every 8 hours 38 in the acute setting.”
BackgroundRational Multimodal Analgesia for Perioperative Pain Management
Joshi, G. P. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01137-y · Cited by 145
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Although it was introduced in clinics more than 100 years ago,(4) paracetamol remains the recommended first-line option for pain management by several scientific societies, and particularly in vulnerable populations such as geriatrics, children, patients with peptic ulcers, and pregnant women.(5,6) Despite its wide us…”
BackgroundGhrayeb, A., Finney, A. C., Agranovich, B., Peled, D., Anand, S. K., McKinney, M. P., Sarji, M., Yang, D., Weissman, N., Drucker, S., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.013 · Cited by 89
Paracetamol for Multimodal Analgesia
Freo, U. (2022) · Pain Management · doi:10.2217/pmt-2021-0116 · Cited by 46
Self-citationPharmacological Pain Treatment in Older Persons
Pickering, G. P., Kotlińska–Lemieszek, A., Škvarč, N. K., O’Mahony, D., Monacelli, F., Knaggs, R., Morel, V., & Kocot-Kępska, M. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01151-8 · Cited by 68
A biocompatible Lossen rearrangement in Escherichia coli
Johnson, N. W., Ortega, M. V., Thorpe, T. W., Era, Y., Kjeldsen, A., Mulholland, K. R., & Wallace, S. (2025) · Nature Chemistry · doi:10.1038/s41557-025-01845-5 · Cited by 38
“Par-acetamol is the first-in-line World Health Organization-recommended treatment for pain and fever worldwide 48 .”
Boylu, S., & Solmaz, R. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127751 · Cited by 33
Huang, L.-Y., Zhang, T., Wang, K., Chang, B., Fu, D., & Chen, X. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00619-0 · Cited by 44
“Its minimal suppression of cyclooxygenase (COX) enzymes coupled with an absence of significant gastrointestinal and renal side effects renders acetaminophen as a preferred, first-line analgesic, particularly favorable for patients ineligible for NSAIDs and the geriatric population [62].”
BackgroundHabibi, B., Bahadori, Y., Pashazadeh, S., & Pashazadeh, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-94178-9 · Cited by 28
Exploring acetaminophen prodrugs and hybrids: a review
Kouznetsov, V. V. (2024) · RSC Advances · doi:10.1039/d4ra00365a · Cited by 31
Silva, F., Costa, G., Veiga, F., Cardoso, C., & Paiva‐Santos, A. C. (2023) · Pharmaceuticals · doi:10.3390/ph16081084 · Cited by 29
“However, it is probably mediated through COX-inhibition in the central nervous system [13,39,40].”
BackgroundPharmacological management of chronic non-cancer pain in frail older people
Wong, G. Y. M. (2022) · Australian Prescriber · doi:10.18773/austprescr.2022.002 · Cited by 23
Stangeland, H., Handal, M., Skurtveit, S. O., Aakvaag, H. F., Dyb, G., Wentzel-Larsen, T., Baumann-Larsen, M., Zwart, J. A., Storheim, K., & Stensland, S. Ø. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02066-8 · Cited by 21
“The increase in use of prescription paracetamol may to some degree result from an intentional shift from prescription of NSAIDs and analgesics with higher potential for misuse, to paracetamol [18].”
BackgroundYajima, M., Sugimoto, M., Sugimura, Y. K., Takahashi, Y., & Kato, F. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109029 · Cited by 22
Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity
Dewanjee, S., Dua, T. K., Paul, P., Dey, A., Vallamkondu, J., Samanta, S., Kandimalla, R. J. L., & Feo, V. D. (2022) · Biomedicines · doi:10.3390/biomedicines10071498 · Cited by 25
Mercado, S. A. S., & Galvis, D. G. V. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26475-7 · Cited by 21
Cysewski, P., Jeliński, T., Przybyłek, M., Nowak, W., & Olczak, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122828 · Cited by 20
“The importance of this drug and its widespread occurrence are the reasons that it is still the subject of many research papers dealing with all aspects of its usage [4,5].”
BackgroundThe Pharmaceutical Potential of α- and β-Amyrins
Viet, T. D., Anh, L. H., Xuan, T. D., & Dong, N. D. (2025) · Nutraceuticals · doi:10.3390/nutraceuticals5030021 · Cited by 29
Saadh, M. J., Amin, A. H., Farhadiyan, S., Sadeghi, M., Shahrtash, S. A., Maaliw, R. R., III, Hanaf, A. S., Kiasari, B. A., Da'i, M., Mirzaei, M., et al. (2023) · Diamond and Related Materials · doi:10.1016/j.diamond.2023.109749 · Cited by 18
Management of Chronic Pain in Elderly Patients: The Central Role of Nurses in Multidisciplinary Care
Markovics, D., Virág, A., & Gadó, K. (2025) · Geriatrics · doi:10.3390/geriatrics10040110 · Cited by 24
“However, it is important to note that at high doses, it can cause liver damage, so it is essential to adhere to the recommended dosage [34] (Table 1).”
Saadatmandi, A., Sohrabi, M. R., & Kabiri-Fard, H. (2022) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2022.104732 · Cited by 17
Montuori, P., Shojaeian, S. Z., Pennino, F., D’Angelo, D., Sorrentino, M., Sarno, S. D., Nubi, R., Nardo, A., & Triassi, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1362632 · Cited by 28
“…for treating muscle pain, dysmenorrhea, arthritic conditions, pyrexia, gout, and migraines, in addition to being employed as opioid-sparing agents in certain acute traumas (Jahnavi et al., 2019; Freo et al., 2021; Ghlichloo and Gerriets, 2023; Murphy et al., 2023; Sisignano and Geisslinger, 2023).”
BackgroundZhang, M., Zhu, W., Liu, H., Pan, K., Li, Q., Zhu, Q., Huang, Y., Wang, C., Hu, J., Jiang, M., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136281 · Cited by 16
Moreira, N. S., Pinheiro, K. M. P., de Sousa, L. R., García, G., Figueredo, F., & Coltro, W. K. T. (2023) · Analytical Methods · doi:10.1039/d3ay01739g · Cited by 17
Neuropharmacology of Neuropathic Pain: A Systematic Review
Mian, M. U., Afzal, M., Butt, A. A., Ijaz, M., Khalil, K., Abbasi, M., Fatima, M., Asif, M. F., Nadeem, S., Jha, S., et al. (2024) · Cureus · doi:10.7759/cureus.69028 · Cited by 25
The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels
Maatuf, Y., Kushnir, Y., Nemirovski, A., Ghantous, M., Iskimov, A., Binshtok, A. M., & Priel, A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413811122 · Cited by 23
“It is commonly found in various medications and is renowned for its effectiveness in managing mild to moderate pain ( 3 ).”
Sinuraya, R. K., Wulandari, C., Amalia, R., & Puspitasari, I. M. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s426290 · Cited by 17
“12,13 Various determinants, including cultural values, individual encounters, and economic circumstances, can influence an individual’s perspectives and actions concerning analgesic medications.”
BackgroundParacetamol: the potential therapeutic pathways defining its clinical use
Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Abdelmaksoud, E. M., Shokr, M. M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01779-x · Cited by 21
Sathappan, A. S., Madhivanan, K., Atchudan, R., Arya, S. K., & Sundramoorthy, A. K. (2025) · ECS Journal of Solid State Science and Technology · doi:10.1149/2162-8777/adad18 · Cited by 13
Varrassi, G., Coluzzi, F., Fornasari, D., Fusco, F., Gianni, W., Guardamagna, V. A., Puntillo, F., & Sotgiu, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247451 · Cited by 13
“It can be prescribed to patients with limited therapeutic options, for those with liver, kidney, or cardiovascular diseases, and for gastrointestinal disorders, as well as in the elderly [27,28].”
BackgroundVentriglia, G., Gervasoni, F., Franco, M., Magni, A., Panico, G., & Iolascon, G. (2023) · Journal of Pain Research · doi:10.2147/jpr.s401550 · Cited by 15
“Nevertheless, although paracetamol use has been long debated due to liver toxicity (albeit at doses higher than 4g/day), it is still recommended by guidelines for the treatment of multiple painful conditions.(31) Figure 4 Level of agreement about the rational of use of thermotherapy (A) and its benefits following ice/…”
BackgroundBarbanti, P., Allais, G., Cevoli, S., Guérzoni, S., Valeriani, M., & Vernieri, F. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00581-x · Cited by 18
“In the Cochrane review published in 2016 [88] assessing the efficacy and safety of acute treatment of episodic TTH in adults, authors concluded that paracetamol 1000 mg provided a small benefit in terms of being pain free at 2 h for people with frequent episodic TTH who have an acute headache of…”
BackgroundNarayanan, I., Rajamanickam, R., Singh, R. K., Singh, P., Prabhu, A. A., Pandey, A., Pradhan, N., Nancharaiah, Y. V., Kumar, V., Selvasembian, R., et al. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07226-4 · Cited by 14
“Paracetamol, one of the most prescribed NSAIDs, possesses hepatotoxic properties, and continuous exposure can lead to liver failure [59].”
Sharif, S. Y., Ali, M. Y. J., Kirazlı, Y., Vlok, I., Zygourakis, C. C., & Zileli, M. (2024) · World Neurosurgery X · doi:10.1016/j.wnsx.2024.100273 · Cited by 18
Nkosi, N., Thabede, P. M., & Shooto, N. D. (2024) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2024.100800 · Cited by 12
Synthesis of Paracetamol‐Appended Bis 1,2,3‐Triazole Analogues as Anti‐Inflammatory Agents
Bathini, V., Thumma, V., Mallikanti, V., Angajala, K. K., & Pochampally, J. (2024) · ChemistrySelect · doi:10.1002/slct.202403390 · Cited by 15
Bala, A., & Mandal, S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00747-6 · Cited by 12
“General adult dose of acetaminophen is 15 mg/kg every 4 h in adults [7], but must not exceed 2gm per day.”
Ndreka, X., Kudr, J., Migliaccio, L., & Zítka, O. (2025) · Electrochimica Acta · doi:10.1016/j.electacta.2025.147049 · Cited by 12
Almohammed, B. A. (2023) · Cureus · doi:10.7759/cureus.33344 · Cited by 23
“However, although paracetamol is relatively considered safer than NSAIDs, its abuse and overdose can lead to hepatotoxicity and even liver failure [12].”
BackgroundDowd, L. A., Cross, A. J., Veal, F. C., Ooi, C. E., & Bell, J. S. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.09.024 · Cited by 12
Effect of paracetamol on the storage cells of Hypsibius exemplaris—ultrastructural analysis
Wieczorkiewicz, F., Sojka, J., & Poprawa, I. (2023) · Zoological Journal of the Linnean Society · doi:10.1093/zoolinnean/zlad051 · Cited by 13
Bagheri, M., Shekaari, H., Mokhtarpour, M., Alavi, A., Dorosti, S., Sillanpää, M. E. T., & Nguyen, K. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124999 · Cited by 10
Changsan, N., Chairam, S., Jarujamrus, P., & Amatatongchai, M. (2022) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/ac5d44 · Cited by 10
“Acetaminophen ( AC, N -acetyl- p -aminophenol ) or well-known paracetamol is one of the most extensively employed drugs [ 5 ] .”
Dowd, L. A., Cross, A. J., Liau, S. J., Jadczak, A. D., Visvanathan, R., Veal, F. C., & Bell, J. S. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01025-5 · Cited by 9
Adhikary, S., Hoque, A. A., Ray, M., Paul, S., Hossain, A., Goswami, S., & Dey, R. K. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04576-w · Cited by 10
“Paracetamol (acetaminophen), a non-opioid analgesic and antipyretic agent [1], is used as a single agent during mild to moderate pain and in combination with an opioid analgesic during severe pain.”
BackgroundCommon UGT1A6 Variant Alleles Determine Acetaminophen Pharmacokinetics in Man
Cerezo-Arias, M. D. L. O., Gómez‐Tabales, J., Martí-Antonio, M., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050720 · Cited by 10
“In addition, acetaminophen causes idiosyncratic drug-induced liver injury (iDILI) [8–10], as NSAIDs do, and it has been hypothesized that functional genetic variations in the COX-enzymes are related to iDILI risk and cross-hypersensitivity to COX-inhibitors [11–15], thus suggesting that patients with impaired COX acti…”
BackgroundInfluentialTen‐year analgesic utilization patterns and economic implications in Portugal
Duarte, N., Martins, J. P., García‐Pedraza, J. Á., & Santos, M. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16333 · Cited by 11
“29,30 The high consumption of naproxen could be due to its long half-life, as well as perceived cardiovascular safety compared with selective COX-2 inhibitors, when used in long-term treatment, such as in OA and rheumatoid arthritis patients.”
The Dangers of Acetaminophen for Neurodevelopment Outweigh Scant Evidence for Long-Term Benefits
Parker, W., Anderson, L. G., Jones, J. P., Anderson, R., Williamson, L. L., Bono‐Lunn, D., & Konsoula, Z. (2023) · Children · doi:10.3390/children11010044 · Cited by 18
“Studies, which are generally conducted with adults rather than children [147,148], show that acetaminophen mitigates pain under a range of conditions and that the drug has been widely accepted as an effective analgesic [149].”
BackgroundCobalt catalyzed condensation interrupted selective transfer hydrogenation using methanol
Dey, S., Thakur, S. D., Sau, A., Panja, D., Roy, T., Zhang, J., Annadata, H. V., & Kundu, S. (2024) · Journal of Catalysis · doi:10.1016/j.jcat.2024.115759 · Cited by 8
Sethi, V. S., van der Laan, L., Gupta, S., & Piros, K. C. (2022) · Journal of Pain Research · doi:10.2147/jpr.s373382 · Cited by 8
Current and emerging COX inhibitors for treating postoperative pain following oral surgery
Pergolizzi, J. V., Breve, F., Magnusson, P., LeQuang, J. A., & Varassi, G. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2161364 · Cited by 8
“may mitigate the emergence of potential adverse events [5,6].”
BackgroundEzugwu, A. L., Anaduaka, E. G., Chibuogwu, C. C., & Ezeorba, T. P. C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15628 · Cited by 11
“This reduces the basic value of nitrogen and oxygen atoms, making the hydroxyl group acid group via delocalization of the charge on the phenoxide ion [25].”
BackgroundEvaluation of diode laser efficacy in treating benign oral soft tissue masses: A case series
Sufiawati, I., Siregar, F. D., Wahyuni, I. S., & Syamsudin, E. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.109075 · Cited by 8
“Paracetamol was indicated as an analgetic [19], while 0.1 % triamcinolone acetonide dental paste (USP) was applied to eliminate inflammation and ulcerative lesions resulting from trauma to the oral mucosa post-surgery [20].”
MethodInfluentialSaadh, M. J., Abdulraheem, M. N., Ahmed, H. H., Mohammed, S. J., Alwan, M., Ali, A. Y., Karimov, D. A., Maaliw, R. R., III, Harismah, K., & Mirzaei, M. (2023) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2023.114421 · Cited by 10
Bello, A. M., & Dye, C. (2023) · Veterinary Medicine and Science · doi:10.1002/vms3.1058 · Cited by 7
“It is also utilised in multimodal analgesia protocols due to its dose-sparing effect when used in combination with other drugs such as non-steroidal anti-inflammatories and/or opioids (Freo et al., 2021;Hyllestedet al., 2002;Westrich et al., 2019).”
BackgroundMethodInfluentialBalancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases
Huang, Y.-T., McCarthy, C., & Jani, M. (2023) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1117674 · Cited by 10
“Paracetamol is widely recommended for pain management, including by the World Health Organisation (WHO, 2019; Freo et al., 2021).”
Shikhani, A., Atassi, Y., Tally, M., & Bandakji, R. (2023) · Journal of Polymer Research · doi:10.1007/s10965-023-03750-2 · Cited by 7
“Paracetamol, or 4-hydroxyacetanilide, is a common analgesic and antipyretic drug [25] that is absorbed along the small intestine [26].”
BackgroundDetection of Pharmaceutical Contamination in Amphipods of Lake Baikal by the HPLC-MS Method
Telnova, T., Morgunova, M. M., Shashkina, S. S., Vlasova, A. A., Dmitrieva, M. E., Shelkovnikova, V. N., Владимировна, М. Е., Imidoeva, N. A., Belyshenko, A. Y., Konovalov, A. S., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13080738 · Cited by 7
“For example, paracetamol (acetaminophen), ibuprofen and azithromycin are of synthetic origin, and are widely used in medicine, veterinary medicine and households [33–36].”
BackgroundCurrent and future advances in practice: mechanical foot pain
Halstead, J., & Munteanu, S. E. (2023) · Rheumatology Advances in Practice · doi:10.1093/rap/rkad081 · Cited by 6
“Short-term relief of symptoms can be achieved using paracetamol and NSAIDs [127].”
BackgroundStegarescu, A., Lung, I., Cârdan, A., Bocșa, M., Turza, A., Lazar, M. D., Dan, M., Tripon, S. C., Kacsó, I., Pintea, S., et al. (2025) · Materials · doi:10.3390/ma18163914 · Cited by 9
“Consequently, it often enters aquatic environments through wastewater discharged from pharmaceutical facilities and hospitals [12,13].”
Kamel, R. M., Mohamed, F. A., & Hosny, N. M. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344902 · Cited by 7
Nili‐Ahmadabadi, A., Abdpour, S., Omidifar, N., Hashemi, S. A., Mousavi, S. M., & Ahmadabadi, M. N. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14430 · Cited by 6
“Acetaminophen (APAP) is the most commonly used medicine to relieve acute and chronic pains to reduce fever (Freo et al., 2021).”
BackgroundStasiowski, M. J., Lyssek-Boroń, A., Zmarzły, N., Marczak, K., & Grabarek, B. O. (2024) · Pharmaceuticals · doi:10.3390/ph17010129 · Cited by 7
“…pain with a single dose administered as preemptive analgesia [13–18], in reducing the incidence of PONV [13,14] and a quite good safety profile [11,19–21] compared to standard nonsteroidal anti-inflammatory drugs (NSAIDs), in terms of safety for the upper intestinal tract and kidneys in patients…”
BackgroundMetabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
Pușcașu, C., Andrei, C., Olaru, O. T., & Zanfirescu, A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010063 · Cited by 6
Ruiz, A. C. F., Sriperumbuduri, S., Shaw, J. L. V., & Clark, E. G. (2022) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581221129753 · Cited by 6
Sridharan, K., Qader, A. M., Hammad, M. A., Jassim, A., Diab, D. E., Abraham, B., Hasan, H. M., Pasha, S. A. A., & Shah, S. (2022) · Metabolites · doi:10.3390/metabo12121235 · Cited by 6
“Paracetamol is then conjugated to sulphate and glucuronide metabolites with a trivial fraction to oxidation product, chiefly by CYP2E1, CYP1A2, CYP3A4, and CYP2D6 enzymes [5].”
BackgroundHarnessing immunity: Immunomodulatory therapies in COVID-19
Velikova, T. V., Valkov, H. Y., Aleksandrova, A., Peshevska-Sekulovska, M., Sekulovski, M., & Shumnalieva, R. (2024) · World Journal of Virology · doi:10.5501/wjv.v13.i2.92521 · Cited by 6
Perrot, S., Eschalier, A., Desmeules, J., Lanteri-Minet, M., & Attal, N. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2076475 · Cited by 6
Striebel, J., Ruppen, W., & Schneider, T. (2023) · Pain Management · doi:10.2217/pmt-2023-0037 · Cited by 9
Pain in Osteoporosis: Current and Future Strategies
Barresi, G., Oliveri, C. V., Morabito, N., Marini, H. R., Xourafa, A., Gaudio, A., Martino, G., Minutoli, L., & Catalano, A. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01225-1 · Cited by 7
“Acetaminophen exerts its effects through cyclooxygenase and endocannabinoid pathways, but also has an influence on cholinergic, noradrenergic, opioid, and serotonergic (5-HT) pathways [135].”
Kumar, C. S. C., Lohith, K. S. M., Ramachandra, M. N., Divakara, T. R., Sumesh, P., Al-Odayni, A.-B. M., Kumar, S. M., & Chandraju, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-28851-4 · Cited by 6
Castanho, N. R. C. M., Marco, N. D., Caetano, É. L. A., Alves, P. L. M., Pickler, T. B., Ibanez, N. L. D. A., Jozala, Â. F., & Grotto, D. (2024) · Molecules · doi:10.3390/molecules29020448 · Cited by 4
“Another pharmaceutical compound that deserves attention is paracetamol, also known as acetaminophen, a potent analgesic and antipyretic both widely used over the counter and prescribed for pain and fever [7,8].”
BackgroundLiu, Y., Yang, R., Zhao, M., Guo, H., Liu, Y., Yan, H., & Liu, Z. (2024) · International Journal of Electrochemical Science · doi:10.1016/j.ijoes.2024.100878 · Cited by 6
Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review
Kašiković-Lečić, S., Javorac, J., Živanović, D., Lovrenski, A., Tegeltija, D., Zvekić-Svorcan, J., & Maksimovic, J. M. (2022) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v127.8739 · Cited by 8
“Despite reports of paracetamol-associated acute liver injury, paracetamol remains a preferred analgesic, particularly for elderly and frail patients (70).”
BackgroundMutić, T., Milikić, J., Bajuk‐Bogdanović, D., Rakočević, L. Z., Stanković, D. M., & Stanković, V. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c04693 · Cited by 4
Sleep quality improves after total knee arthroplasty: Addressing early disturbance and risk factors
Mehta, N., Sancheti, P. K., Shyam, A. K., Patil, K., Gugale, S., Obaid, N., Sisodia, Y., & Sanghavi, S. A. (2024) · Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine · doi:10.1016/j.jisako.2024.100373 · Cited by 5
Effects of Paracetamol on the Development of Zebrafish (Danio rerio)
Dewanti, A. I. A., Kunjirika, T. P., Putri, R. R. R. A. D., Adaninggar, A., Raharjeng, A. R. P., Retnoaji, B., Nuriliani, A., Sofyantoro, F., Septriani, N. I., & Saragih, H. T. S. S. G. (2023) · Pertanika journal of tropical agricultural science · doi:10.47836/pjtas.46.4.06 · Cited by 6
Evaluating pain management in older people after orthopaedic surgery – a study in Jordan
Almagharbeh, W. T. (2024) · Nursing Older People · doi:10.7748/nop.2024.e1491 · Cited by 4
Melaku, T., Mekonnen, Z., Tucho, G. T., Viana, J., Årdal, C., & Jahre, M. (2025) · Logistics · doi:10.3390/logistics9010015 · Cited by 6
“Paracetamol, also known as acetaminophen, is a widely used over-the-counter (OTC) medication for the relief of pain and management of fever [16,17].”
Perigo da automedicação irresponsável do Paracetamol: uma revisão de literatura
Neca, C. S. M., da Silva, F. A., Medeiros, K. N. D., Gomes, L. R. D. O., Morais, P. A., & Costa, S. M. (2022) · Research Society and Development · doi:10.33448/rsd-v11i17.38103 · Cited by 4
Sethi, V. S., Li, Q., Trocóniz, I. F., van der Laan, L., Cox, E. H., & Pasqua, O. E. D. (2024) · Pain and Therapy · doi:10.1007/s40122-023-00566-2 · Cited by 6
“However, most clinical guidelines for OA management suggest short-term or episodic use of acetaminophen at \ 3 g/day and/or not exceeding 4 g/day, e.g., in elderly subjects, with joint consideration of its analgesic effect and potential safety issues [15, 16, 35, 36].”
BackgroundZhang, X., Zhou, N., Huo, F., & Yin, C. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112364 · Cited by 6
Tiz, D. B. (2026) · Medicines · doi:10.3390/medicines13030022 · Cited by 8
Sridharan, K., Mulubwa, M., & Qader, A. M. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00841-9 · Cited by 3
“Acetaminophen is a hydrophilic drug, and the most used antipyretic and analgesic drug worldwide [6].”
BackgroundThomas, O. E., Akin-Taylor, A., Oyetunde, Y. S., & Gana, D. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00544-7 · Cited by 4
“Although paracetamol is largely well tolerated and regarded as safe since it does not cause gastrointestinal damage, its concomitant use with CBZ has been reported to increase severity of paracetamol hepatotoxicity [16, 17].”
BackgroundThe protective effect of Thai rice bran on N-acetyl-ρ-aminophen-induced hepatotoxicity in mice
Wanyo, P., & So-In, C. (2024) · Research in Pharmaceutical Sciences · doi:10.4103/rps.rps_210_23 · Cited by 3
“At therapeutic concentrations, it is safe; an adult’s typical dose is 10-15 mg/kg, and a maximum daily intake of 3-4 g is recommended (1,2).”
BackgroundJADHAV, S., BHOIR, G., & Jain, V. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024.v17i4.49544 · Cited by 3
Nastiti, A., Utami, R. R., Ramadhina, S. Q., Fathonah, N., Yoga, G. P., Ariesyady, H. D., Kusumah, S. W. D., & Hidayat, H. (2025) · International Journal of Environmental Health Research · doi:10.1080/09603123.2024.2445162 · Cited by 3
“Paracetamol, with the highest total annual usage at 426 tons/year, is a widely used analgesic and antipyretic, reflecting its importance in treating common ailments such as headaches, fevers, and minor pains (Freo et al. 2021).”
Costa, L. R. D. C., Nunes, K. G. P., Jurado-Davila, V., Carissimi, É., & Féris, L. A. (2025) · Environmental Nanotechnology Monitoring & Management · doi:10.1016/j.enmm.2025.101045 · Cited by 3
Kouznetsov, V. V., Lamus, D. C., & Galvis, C. E. P. (2023) · Reactions · doi:10.3390/reactions4030020 · Cited by 2
How to deal with pain in the emergency department - pain management review
Beutler, K., Bijata, B., Burek, D., Paszkowska, A., Kujawa, A., Matuszewska, U., & Nykowska, A. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.51.012 · Cited by 3
Collamore, G., DiCorcia, M. J., Nagpal, Y., Fiedler, L. M., Garone, M. A., DeMets, D. L., Maki, D. G., & Hennekens, C. H. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.03.003 · Cited by 3
Bosnalı, W., Korkmaz, Ş., Mülazımoğlu, A. D., & Mülazımoğlu, İ. E. (2025) · ACS Omega · doi:10.1021/acsomega.4c08502 · Cited by 3
Dani, D. H., Naqvi, S. B. S., Akram, M., Ullah, M., Khaliq, S. A., Akhtar, M. M., Abdullah, O., Badshah, S. F., Bourhia, M., Shazly, G. A., et al. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00808-9 · Cited by 2
“Compared to other analgesics such as non-steroidal anti-inflammatory medications (NSAIDs) and opioids, it has a good safety profile and a minimal risk of drug interactions [1].”
BackgroundIslam, M. T., Medha, M. M., Islam, M. A., Mondal, M., Saha, S., Sarkar, C. K., & Coutinho, H. D. M. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100132 · Cited by 2
Mazdi, N. T. A., Zin, N. A. M. M., Hisham, M. A. K., Rus, S. M., Haris, M. S., & Chatterjee, B. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2495131 · Cited by 4
“…function and aa’s immune-enhancing properties hold significant potential, particularly in the context of infectious diseases like flu and fever [2,3]. administering two separate medications to patients can present challenges, potentially affecting compliance. therefore, a fixed dose…”
Paracetamol and Caffeine Combination in Pain Management: A Narrative Review
Lantéri‐Minet, M., & Pegahi, R. (2025) · Pain Research and Management · doi:10.1155/prm/9166828 · Cited by 4
“It has a unique clinical pharmacological profle with a potent analgesic and antipyretic efects [2].”
Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide
Hussein, M. T. E., & Fraser, L. (2025) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2025.105501 · Cited by 2
Metadata
- Authors
- Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E.
- Affiliations
- University of Padua (IT)
- University of Milan (IT)
- University of Brescia (IT)
- Corresponding author
- Freo, Ulderico
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-07-31
- Volume
- 10
- Issue
- 15
- Pages
- 3420
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC8347233
- OpenAlex
- W3188836359
- Cited by
- 208
- References
- 154
- Citations by year
- 2026: 39 · 2025: 54 · 2024: 43 · 2023: 48 · 2022: 22 · 2021: 2
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Fondazione Cariplo (2016-1006)
- Fondazione Umberto Veronesi (2016-1006)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- paracetamol, musculoskeletal pain, chronic pain, acute pain, guideline recommendations, NSAID combination therapy, hepatotoxicity, genetic polymorphism, elderly patients, vulnerable patients, multimodal analgesia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

